Our device gives real-time data about the concentration of biologic drugs in bioreactors. This helps manufacturers decrease costs and increase revenue.
The Tekla by Circle Technologies automatically measures the concentration of drug in bioreactors. We filed an International PCT Patent in 2014 and in 2015 received opinions supporting the novelty of our device. We are in a large growth market: spending on cell culture equipment for biologic drugs was $15B in 2013 and will be $25B by 2018.